Literature DB >> 26215116

Acute infection by hepatitis E virus with a slight immunoglobulin M antibody response.

Yuki Inagaki1, Yukio Oshiro, Mamiko Imanishi, Kazunori Ishige, Masaharu Takahashi, Hiroaki Okamoto, Nobuhiro Ohkohchi.   

Abstract

The anti-hepatitis E virus (HEV) immunoglobulin (Ig) M antibody response is generally regarded as a useful marker for diagnosing primary infection. However, in some cases, this antibody is not detected during the acute phase of infection. An 81-year-old man with stable membranous nephropathy who presented with asymptomatic acute liver dysfunction came to our hospital. HEV RNA of genotype 3 was detected in his serum, and he was diagnosed with acute hepatitis E. According to an enzyme-linked immunosorbent assay, high-level positivity for anti-HEV IgG and IgA antibodies was observed, but the assay was negative for IgM antibody throughout the clinical course of infection. The patient was not immunosuppressed. We further investigated the presence of IgM antibody using two other polyclonal antibodies against human IgM as secondary antibodies and another recombinant ORF2 protein of genotype 3 as an immobilized antigen. IgM was weakly detected in the serum during the acute phase only by the test with the antigen of genotype 3. Multi-genotype antigens can detect a slight IgM antibody response; however, anti-HEV IgA is more useful in diagnosing primary HEV infection, particularly in cases with a low IgM antibody response.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26215116     DOI: 10.1007/s12328-015-0589-4

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  18 in total

1.  A proposal of the diagnostic scale of drug-induced liver injury.

Authors:  Hajime Takikawa; Morikazu Onji
Journal:  Hepatol Res       Date:  2005-08-15       Impact factor: 4.288

2.  Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan.

Authors:  Takehiro Mitsui; Yukie Tsukamoto; Akinori Hirose; Shigeru Suzuki; Chikao Yamazaki; Kazuo Masuko; Fumio Tsuda; Kazunori Endo; Masaharu Takahashi; Hiroaki Okamoto
Journal:  J Med Virol       Date:  2006-08       Impact factor: 2.327

3.  Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan.

Authors:  Hitoshi Mizuo; Yasuyuki Yazaki; Kenji Sugawara; Fumio Tsuda; Masaharu Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Med Virol       Date:  2005-07       Impact factor: 2.327

Review 4.  Hepatitis E.

Authors:  Nassim Kamar; Richard Bendall; Florence Legrand-Abravanel; Ning-Shao Xia; Samreen Ijaz; Jacques Izopet; Harry R Dalton
Journal:  Lancet       Date:  2012-04-30       Impact factor: 79.321

5.  Icteric acute hepatitis E with no response of immunoglobulin M class anti-hepatitis E virus antibody.

Authors:  Yasuhiro Takikawa; Yasuhiro Miyamoto; Mio Onodera; Hidekatu Kuroda; Kazuhiro Kasai; Akio Miyasaka; Masaharu Takahashi; Hiroaki Okamoto; Kazuyuki Suzuki
Journal:  Hepatol Res       Date:  2012-11       Impact factor: 4.288

6.  Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan.

Authors:  Hitoshi Mizuo; Kazuyuki Suzuki; Yasuhiro Takikawa; Yoshiki Sugai; Hajime Tokita; Yoshihiro Akahane; Keiichi Itoh; Yuhko Gotanda; Masaharu Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

Review 7.  Hepatitis E: an emerging awareness of an old disease.

Authors:  R H Purcell; S U Emerson
Journal:  J Hepatol       Date:  2008-01-02       Impact factor: 25.083

8.  A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route.

Authors:  Keiji Matsubayashi; Jong-Hon Kang; Hidekatsu Sakata; Kazuaki Takahashi; Motohiro Shindo; Masaru Kato; Shinichiro Sato; Toshiaki Kato; Hiroyuki Nishimori; Kunihiko Tsuji; Hiroyuki Maguchi; Jun-Ichi Yoshida; Hiroshi Maekubo; Shunji Mishiro; Hisami Ikeda
Journal:  Transfusion       Date:  2008-07       Impact factor: 3.157

9.  Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response.

Authors:  R Bendall; V Ellis; S Ijaz; P Thurairajah; H R Dalton
Journal:  J Med Virol       Date:  2008-01       Impact factor: 2.327

10.  Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system.

Authors:  Masaharu Takahashi; Yu Hoshino; Toshinori Tanaka; Hideyuki Takahashi; Tsutomu Nishizawa; Hiroaki Okamoto
Journal:  Arch Virol       Date:  2008-02-12       Impact factor: 2.574

View more
  1 in total

Review 1.  Zoonotic Hepatitis E Virus: An Ignored Risk for Public Health.

Authors:  Yuchen Nan; Chunyan Wu; Qin Zhao; En-Min Zhou
Journal:  Front Microbiol       Date:  2017-12-04       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.